| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Equillium, Inc. (EQ) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 5 sells. EQ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.75M | $5.40M | - | |
| Pres | 762.0K | $2.35M | -230,975 | |
| Dir | 70.0K | $215.9K | - | |
| Dir | 70.0K | $215.9K | - | |
| Other | 70.0K | $215.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2020 | Connelly Stephen79 | Chief Scientific Officer | Sell | 250,000 | $8.13 | $2,033,475.00 | -19.3% | |
| Feb 18, 2020 | Keyes Jason A72 | Chief Financial Officer | Sell | 5,000 | $5.03 | $25,137.50 | -3.7% | |
| Jan 21, 2020 | Keyes Jason A72 | Chief Financial Officer | Sell | 5,000 | $4.41 | $22,043.00 | -3.6% | |
| Sep 3, 2019 | Keyes Jason A72 | Chief Financial Officer | Sell | 5,000 | $3.60 | $17,980.50 | -3.5% | |
| Aug 1, 2019 | Keyes Jason A72 | Chief Financial Officer | Sell | 5,000 | $3.99 | $19,941.00 | -3.4% |